A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers

Ernst Mayerhofer1,2, Franz Ratzinger1, Nina Elvira Kienreich3

  • 1Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Insights

A short-term, multidisciplinary program significantly improved body composition, insulin resistance, and inflammation in obese children. Early intervention is crucial for managing obesity-related health issues.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Syndrome Research
  • Public Health and Nutrition

Background:

  • Childhood obesity is a growing concern, linked to insulin resistance and systemic inflammation, increasing diabetes risk.
  • Moderate evidence supports intervention programs for obesity sequelae, necessitating further investigation into effective strategies.
  • Early detection of insulin resistance and inflammation in obese youth is critical for timely management.

Purpose of the Study:

  • To evaluate the impact of a multidisciplinary intervention on insulin resistance and metaflammation in childhood obesity.
  • To assess changes in body mass index standard deviation score (BMI-SDS), insulin resistance (HOMA-IR), and inflammatory markers.
  • To investigate the effects on adipokine levels (leptin and adiponectin) in overweight and obese children.

Main Methods:

  • A prospective 5-month study involving 236 overweight/obese children aged 10-14.
  • Intervention included sports, psychotherapy, and nutritional counseling.
  • Primary endpoints: BMI-SDS and HOMA-IR; Secondary endpoints: CRP, leptin, and adiponectin levels.

Main Results:

  • Significant reductions observed in BMI-SDS, HOMA-IR, CRP, and leptin levels post-intervention.
  • Significant increase in adiponectin levels noted.
  • Leptin levels showed a strong positive correlation with BMI-SDS and total fat mass.

Conclusions:

  • Short-term, multidisciplinary interventions effectively improve body composition, insulin sensitivity, and reduce inflammation in childhood obesity.
  • Highlights the direct link between obesity and its pathological consequences, emphasizing early intervention.
  • Sustained lifestyle changes are likely necessary for long-term benefits and consolidation of results.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
565
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
189
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
272
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174